
Currently, the principal zzso for the preparation of zzso zzso zzso target either zzso or zzso for zzso zzso drugs for delivery to target cells expressing zzso zzso All of these zzso generate populations of molecules which differ in critical properties which are known to affect zzso zzso and the therapeutic zzso Of key interest are methods to minimize this zzso to achieve zzso product profiles and zzso A current trend in the development of zzso is the evaluation of suitable targets, zzso and zzso occurring well before process development to produce zzso of clinical zzso This creates a need for an ability to generate comparably high-quality products early in development and at sufficient scale for evaluating in zzso potency and in zzso zzso as well as the early identification of any deficiencies in critical quality attributes including zzso and zzso Here we elaborate detailed protocols using zzso chemistry for the zzso to reduce hinge zzso in zzso by several zzso zzso We present a method for the initial characterization of the zzso reaction using zzso zzso as a drug zzso a 5 zzso scale drug zzso to provide material for initial characterization including cell proliferation zzso and a 150 zzso scale process for performing efficacy studies in small zzso These methods yield zzso predictable product profiles at high yield and with low zzso These procedures include details relevant to the execution of these methods in a safe and contained manner within a typical laboratory zzso 

